aDepartment of Surgery, Medical University of Vienna, Vienna, Austria;
bDepartment of Hepatology and Gastroenterology, Campus Virchow Klinikum, Charité Universitätsmedizin
Berlin, Berlin, Germany;
cCentro de Oncologia, Hospital Sírio Libanês, São Paulo, Brazil;
dDepartment of Endocrinology and Metabolism, Hadassah University Hospital, Mevasseret
Tsion, Israel;
eDepartment of Endocrinology, Erciyes University Medical School, Kayseri, Turkey;
fNeuroendocrine Tumor Center of Excellence, Rigshospitalet, Copenhagen University Hospital,
Copenhagen, Denmark;
gDepartment of Medical Sciences, Endocrine Oncology Unit, University Hospital, Uppsala,
Sweden;
hInstitute of Pathology, University of Bern, Bern, Switzerland;
iNeuroendocrine Tumour Unit, Royal Free Hospital, London, UK;
jDepartment of Clinical Oncology, Institute Alexander Fleming, Buenos Aires, Argentina;
kNational NET Centre, St. Vincent's University and Department of Clinical Medicine,
St. James Hospital and Trinity College, Dublin, Ireland;
lDepartment of Internal Medicine, Division of Nuclear Medicine, Erasmus Medical Center,
Rotterdam, The Netherlands;
mBeatson Oncology Centre, Gartnavel General Hospital, Glasgow, UK;
nDepartment of Surgery, CHU Robert Debré, Reims, France